U.S. regulators say J&J’s single-dose vaccine protects against COVID-19. The report says overall the vaccine is about 66% effective at preventing moderate to severe COVID. This sets the stage for a final decision on FDA emergency use.
FDA says single-dose shot from J&J prevents severe COVID
